<!DOCTYPE html>
<html XMLNS="http://www.w3.org/1999/xhtml">
<head>
<meta NAME="generator" CONTENT=
"HTML Tidy for HTML5 for Mac OS X version 5.4.0" />
<title>8-K</title>
</head>
<body BGCOLOR="white">
<p STYLE=
"line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">
&nbsp;</p>
<p STYLE=
"line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">
&nbsp;</p>
<p STYLE=
"margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman"
ALIGN="center"><b>UNITED STATES</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman"
ALIGN="center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"
ALIGN="center"><b>WASHINGTON, DC 20549</b></p>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<center>
<p STYLE=
"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">
&nbsp;</p>
</center>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman"
ALIGN="center"><b>FORM 8-K</b></p>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<center>
<p STYLE=
"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">
&nbsp;</p>
</center>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"
ALIGN="center"><b>CURRENTREPORT</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"
ALIGN="center"><b>PURSUANT TO SECTION 13 OR 15(d)</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"
ALIGN="center"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"
ALIGN="center"><b>Date of Report (Date of earliest event reported):
May 22, 2018</b></p>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<center>
<p STYLE=
"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">
&nbsp;</p>
</center>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman"
ALIGN="center"><b>CytoDyn Inc.</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"
ALIGN="center"><b>(Exactname of registrant as specified in its
charter)</b></p>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<center>
<p STYLE=
"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">
&nbsp;</p>
</center>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0"
STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt"
ALIGN="center">
<tr>
<td WIDTH="34%"></td>
<td VALIGN="bottom"></td>
<td WIDTH="32%"></td>
<td VALIGN="bottom" WIDTH="1%"></td>
<td WIDTH="32%"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top" ALIGN="center"><b>Delaware</b></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top" ALIGN="center"><b><font STYLE=
"white-space:nowrap">000-49908</font></b></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top" ALIGN="center"><b><font STYLE=
"white-space:nowrap">75-3056237</font></b></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td VALIGN="top" ALIGN="center">
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>(State or other jurisdiction</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>of incorporation)</b></p>
</td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top" ALIGN="center">
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>(SEC</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>File Number)</b></p>
</td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top" ALIGN="center">
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>(I.R.S. Employer</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>Identification No.)</b></p>
</td>
</tr>
</table>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0"
STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
ALIGN="center">
<tr>
<td WIDTH="50%"></td>
<td VALIGN="bottom" WIDTH="1%"></td>
<td WIDTH="48%"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top" ALIGN="center">
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"
ALIGN="center"><b>1111 Main Street, Suite 660</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"
ALIGN="center"><b>Vancouver, Washington</b></p>
</td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="bottom" ALIGN="center"><b>98660</b></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td VALIGN="top" ALIGN="center"><b>(Address of principal executive
offices)</b></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top" ALIGN="center"><b>(Zip Code)</b></td>
</tr>
</table>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"
ALIGN="center"><b>Registrant’s telephone number, including area
code:<font STYLE=
"white-space:nowrap">(360)&nbsp;980-8524</font></b></p>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<center>
<p STYLE=
"line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">
&nbsp;</p>
</center>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Check the appropriate box belowif the Form <font STYLE=
"white-space:nowrap">8-K</font> filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):</p>
<p STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="4%" VALIGN="top" ALIGN="left">☐</td>
<td ALIGN="left" VALIGN="top">Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425)</td>
</tr>
</table>
<p STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="4%" VALIGN="top" ALIGN="left">☒</td>
<td ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule
<font STYLE="white-space:nowrap">14a-12</font> under the Exchange
Act (17 CFR <font STYLE=
"white-space:nowrap">240.14a-12)</font></td>
</tr>
</table>
<p STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="4%" VALIGN="top" ALIGN="left">☐</td>
<td ALIGN="left" VALIGN="top"><font STYLE=
"white-space:nowrap">Pre-commencement</font> communications
pursuant to Rule <font STYLE="white-space:nowrap">14d-2(b)</font>
under the Exchange Act (17 CFR<font STYLE=
"white-space:nowrap">240.14d-2(b))</font></td>
</tr>
</table>
<p STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="4%" VALIGN="top" ALIGN="left">☐</td>
<td ALIGN="left" VALIGN="top"><font STYLE=
"white-space:nowrap">Pre-commencement</font> communications
pursuant to Rule <font STYLE="white-space:nowrap">13e-4(c)</font>
under the Exchange Act (17 CFR<font STYLE=
"white-space:nowrap">240.13e-4(c))</font></td>
</tr>
</table>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indicate by check mark whether the registrant is an emerging growth
company asdefined in as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule <font STYLE=
"white-space:nowrap">12b-2</font> of the Securities Exchange Act of
1934 <font STYLE="white-space:nowrap">(§240.12b-2</font> ofthis
chapter).</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Emerging growth company&nbsp;&nbsp;☐</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new orrevised financial accounting standards
provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;☐</p>
<p STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<p STYLE=
"line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">
&nbsp;</p>
<p STYLE=
"line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">
&nbsp;</p>
<p STYLE='page-break-before:always'></p>
<hr SIZE="3" STYLE="COLOR:#999999" WIDTH="100%" ALIGN="center" />
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="9%" VALIGN="top" ALIGN="left">
<b>Item&nbsp;1.01.</b></td>
<td ALIGN="left" VALIGN="top"><b>Entry into a Material Definitive
Agreement.</b></td>
</tr>
</table>
<p STYLE=
"margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
On May 22, 2018, CytoDyn Inc. (the“<b>Company</b>”) entered into
Subscription Agreements (the “<b>Subscription Agreements</b>”) with
certain investors (the “<b>Investors</b>”) for the sale by the
Company of 4,640,000 shares (the “<b>CommonShares</b>”) of the
Company’s common stock, par value $0.001 per share (the “<b>Common
Stock</b>”), in a registered direct offering (the “<b>Offering</b>”
). The Investors in the Offering also received warrants topurchase
4,640,000 shares of Common Stock (the “<b>Warrants</b>”). Each
share of Common Stock was sold together with one Warrant to
purchase one share of Common Stock for a combined purchase price of
$0.50.</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The aggregate gross proceeds for the sale of the Common Shares and
Warrants will be approximately $2.3 million. Subject to certain
ownership limitations, theWarrants will be exercisable commencing
on the issuance date at an exercise price equal to $0.75 per share
of Common Stock, subject to adjustments as provided under the terms
of the Warrants. The Warrants are exercisable for five years from
the dateof issuance. The closing of the sales of these securities
under the Subscription Agreements is expected to occur on or about
May 22, 2018.</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The netproceeds to the Company from the transactions, after
deducting the fees and expenses of the Placement Agent, as defined
below (not including the Placement Agent Warrants, as defined
below), the Company’s estimated offering expenses, andexcluding the
proceeds, if any, from the exercise of the Warrants, are expected
to be approximately $2.1 million. The Company intends to use the
net proceeds from the transactions to fund clinical trials for its
lead product candidate and forgeneral corporate purposes.</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The securities sold in the Offering were offered and sold by the
Company pursuant to an effective shelf registrationstatement on
<font STYLE="white-space:nowrap">Form&nbsp;S-3,</font> which was
initially filed with the Securities and Exchange Commission (the 
“<b>SEC</b>”) on February&nbsp;23, 2018 and subsequently declared
effective on March&nbsp;7,2018 (File <font STYLE=
"white-space:nowrap">No.&nbsp;333-223195)</font> (the 
“<b>Registration Statement</b>”), and the base prospectus dated as
of March&nbsp;7, 2018 contained therein. The Company will file a
prospectus supplement with theSEC in connection with the sale of
the securities.</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The representations, warranties and covenants contained in the
Subscription Agreements were madesolely for the benefit of the
parties to the Subscription Agreements. In addition, such
representations, warranties and covenants (i)&nbsp;are intended as
a way of allocating the risk between the parties to the
Subscription Agreements and not asstatements of fact, and
(ii)&nbsp;may apply standards of materiality in a way that is
different from what may be viewed as material by stockholders of,
or other investors in, the Company. Accordingly, the forms of the
Subscription Agreements areincluded with this filing only to
provide investors with information regarding the terms of
transaction, and not to provide investors with any other factual
information regarding the Company. Stockholders should not rely on
the representations,warranties and covenants or any descriptions
thereof as characterizations of the actual state of facts or
condition of the Company or any of its subsidiaries or affiliates.
Moreover, information concerning the subject matter of the
representationsand warranties may change after the date of the
Subscription Agreements, which subsequent information may or may
not be fully reflected in public disclosures.</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Pursuant to the Placement Agent Agreement, dated as of May&nbsp;4,
2018 (the “<b>Placement Agent Agreement</b>”) with Paulson
Investment Company,LLC (the “<b>Placement Agent</b>”), the Company
has agreed to pay the Placement Agent a cash fee equal to 9% of the
gross proceeds received by the Company from qualified investors
first introduced to the Company in the Offering by thePlacement
Agent, as well as a <font STYLE=
"white-space:nowrap">one-time</font> <font STYLE=
"white-space:nowrap">non-accountable</font> expense fee of $25,000
for aggregate expenses incurred collectively in the Offering.
Pursuant to the PlacementAgent Agreement, the Company also agreed
to grant to the Placement Agent or its designees warrants to
purchase up to 8% of the aggregate number of shares sold to
qualified investors at an exercise price equal to 110% of the price
of the Common Stocksold in the Offering, or $0.55 per share (the 
“<b>Placement Agent Warrants</b>”). The Placement Agent Warrants
provide for cashless exercise. The Placement Agent is not entitled
to compensation relating to Investors not first introduced byit to
the Company in this Offering. The Placement Agent Agreement has
indemnity and other customary provisions for transactions of this
nature. The Placement Agent Warrants and the shares issuable upon
exercise of the Placement Agent Warrants willbe issued in reliance
on the exemption from registration provided by
Section&nbsp;4(a)(2)&nbsp;of the Securities Act as transactions not
involving a public offering and in reliance on similar exemptions
under applicable state laws. The PlacementAgent Agreement is filed
as Exhibit 10.2 to this Current Report on Form <font STYLE=
"white-space:nowrap">8-K</font> and is incorporated herein by
reference.</p>
<p STYLE='page-break-before:always'></p>
<hr SIZE="3" STYLE="COLOR:#999999" WIDTH="100%" ALIGN="center" />
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The form of the Subscription Agreement is filed as Exhibit 10.1 to
this Current Report on Form&nbsp;8-K. The form of Warrant is filed
as Exhibit 4.1 to this Current Report on Form <font STYLE=
"white-space:nowrap">8-K.</font> The foregoing summaries of the
terms of these documents are subject to, andqualified in their
entirety by, such documents, which are incorporated herein by
reference.</p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The legal opinion and consent of Lowenstein Sandler LLPrelating to
the securities are filed as Exhibit 5.1 to this Current Report on
Form <font STYLE="white-space:nowrap">8-K.</font></p>
<p STYLE=
"margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<b>Additional Informationand Where to Find It</b></p>
<p STYLE=
"margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
This document may be deemed to be solicitation material in respect
of the special meeting of stockholders to be held on June 7,2018.
In connection with the special meeting, the Company has filed a
definitive proxy statement with the United States Securities and
Exchange Commission (the “SEC”) on May 8, 2018. BEFORE MAKING ANY
VOTING OR INVESTMENT DECISIONS,INVESTORS AND SECURITY HOLDERS ARE
URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER RELEVANT
DOCUMENTS FILED WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT
INFORMATION ABOUT THE SPECIAL MEETING. The definitive proxy
statement has been mailedto stockholders who are entitled to vote
at the special meeting. Stockholders will also be able to obtain a
copy of the definitive proxy statement free of charge by directing
a request to: 1111 Main Street, Suite 660, Vancouver, Washington
98660,telephone: (360) 980-8524. In addition, the definitive proxy
statement is available free of charge at the SEC’s website,
www.sec.gov.</p>
<p STYLE=
"margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<b>Participants in the Solicitation</b></p>
<p STYLE=
"margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The Company and itsdirectors and executive officers and other
employees may be deemed to be participants in the solicitation of
proxies in respect of the special meeting. Information regarding
the Company’s directors and executive officers is available in
theCompany’s proxy statement for its 2017 annual meeting of
stockholders, which was filed with the SEC on July 24, 2017.
Information regarding any persons who may, under the rules of the
SEC, be considered participants in the solicitation ofstockholders
in connection with the special meeting is set forth in the
definitive proxy statement filed with the SEC on May 8, 2018. These
documents are available free of charge at the SEC’s website at
www.sec.gov, and by mail at: 1111 MainStreet, Suite 660, Vancouver,
Washington 98660, telephone: (360) 980-8524.</p>
<p STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="9%" VALIGN="top" ALIGN="left">
<b>Item&nbsp;3.02.</b></td>
<td ALIGN="left" VALIGN="top"><b>Unregistered Sales of Equity
Securities.</b></td>
</tr>
</table>
<p STYLE=
"margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
See Item&nbsp;1.01 with respect to the Placement AgentWarrants.</p>
<p STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<tr STYLE="page-break-inside:avoid">
<td WIDTH="9%" VALIGN="top" ALIGN="left">
<b>Item&nbsp;9.01.</b></td>
<td ALIGN="left" VALIGN="top"><b>Financial Statements and
Exhibits.</b></td>
</tr>
</table>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0"
STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt"
ALIGN="center">
<tr>
<td></td>
<td VALIGN="bottom" WIDTH="4%"></td>
<td></td>
<td VALIGN="bottom" WIDTH="3%"></td>
<td WIDTH="90%"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td VALIGN="bottom" NOWRAP="nowrap" ALIGN="center">
<p STYLE=
"margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:9.75pt; display:inline; font-size:8pt; font-family:Times New Roman;"
ALIGN="center"><b>(d)</b></p>
</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap" ALIGN="center">
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"
ALIGN="center"><b>Exhibit</b></p>
<p STYLE=
"margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:27.80pt; display:inline; font-size:8pt; font-family:Times New Roman;"
ALIGN="center">
<b>&nbsp;&nbsp;&nbsp;&nbsp;No.&nbsp;&nbsp;&nbsp;&nbsp;</b></p>
</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap" ALIGN="center">
<p STYLE=
"margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:41.50pt; display:inline; font-size:8pt; font-family:Times New Roman;"
ALIGN="center"><b>Description.</b></p>
</td>
</tr>
<tr STYLE="font-size:1pt">
<td HEIGHT="8"></td>
<td HEIGHT="8" COLSPAN="2"></td>
<td HEIGHT="8" COLSPAN="2"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="top">&nbsp;&nbsp;4.1</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap"><a HREF="d585472dex41.htm">Form
of Warrant Agreement</a></td>
</tr>
<tr STYLE="font-size:1pt">
<td HEIGHT="8"></td>
<td HEIGHT="8" COLSPAN="2"></td>
<td HEIGHT="8" COLSPAN="2"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="top">&nbsp;&nbsp;5.1</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap"><a HREF=
"d585472dex51.htm">Opinion of Lowenstein Sandler LLP</a></td>
</tr>
<tr STYLE="font-size:1pt">
<td HEIGHT="8"></td>
<td HEIGHT="8" COLSPAN="2"></td>
<td HEIGHT="8" COLSPAN="2"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="top">10.1</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap"><a HREF=
"d585472dex101.htm">Form of Subscription Agreement</a></td>
</tr>
<tr STYLE="font-size:1pt">
<td HEIGHT="8"></td>
<td HEIGHT="8" COLSPAN="2"></td>
<td HEIGHT="8" COLSPAN="2"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="top">10.2</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap"><a HREF=
"d585472dex102.htm">Placement Agent Agreement</a></td>
</tr>
<tr STYLE="font-size:1pt">
<td HEIGHT="8"></td>
<td HEIGHT="8" COLSPAN="2"></td>
<td HEIGHT="8" COLSPAN="2"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="top">23.1</td>
<td VALIGN="bottom">&nbsp;&nbsp;</td>
<td VALIGN="bottom" NOWRAP="nowrap"><a HREF=
"d585472dex51.htm">Consent of Lowenstein Sandler LLP (included in
the opinion of Lowenstein Sandler LLP as Exhibit&nbsp;5.1)</a></td>
</tr>
</table>
<p STYLE='page-break-before:always'></p>
<hr SIZE="3" STYLE="COLOR:#999999" WIDTH="100%" ALIGN="center" />
<p STYLE=
"margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"
ALIGN="center"><b>SIGNATURES</b></p>
<p STYLE=
"margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersignedhereunto duly authorized.</p>
<p STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
&nbsp;</p>
<table CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0"
STYLE=
"BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">
<tr>
<td WIDTH="45%"></td>
<td VALIGN="bottom" WIDTH="1%"></td>
<td WIDTH="4%"></td>
<td VALIGN="bottom"></td>
<td WIDTH="4%"></td>
<td VALIGN="bottom" WIDTH="1%"></td>
<td WIDTH="44%"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top" COLSPAN="3">CytoDyn Inc.</td>
</tr>
<tr STYLE="font-size:1pt">
<td HEIGHT="16"></td>
<td HEIGHT="16" COLSPAN="2"></td>
<td HEIGHT="16" COLSPAN="2"></td>
<td HEIGHT="16" COLSPAN="2"></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top">May 22, 2018</td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top">By:</td>
<td VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">
&nbsp;</td>
<td VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><i>/s/
Michael D. Mulholland</i></td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top">Name:</td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top">Michael D. Mulholland</td>
</tr>
<tr STYLE=
"page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td VALIGN="top"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="bottom"></td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="top">Title:</td>
<td VALIGN="bottom">&nbsp;</td>
<td VALIGN="bottom">Chief Financial Officer</td>
</tr>
</table>
</body>
</html>

